Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma

A retrospective survey of 112 adult patients in Japan

E. Kusumi, M. Kami, Y. Kanda, N. Murashige, Y. Kishi, R. Suzuki, K. Takeuchi, T. E. Tanimoto, Takehiko Mori, K. Muta, T. Tamaki, Y. Tanaka, H. Ogawa, T. Yamane, S. Taniguchi, Y. Takaue

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

We conducted a nation-wide survey of 112 adult Japanese patients who underwent reduced-intensity stem cell transplantation (RIST) from 1999 to 2002. Underlying diseases included indolent (n = 45), aggressive (n = 58) and highly aggressive lymphomas (n = 9). Median age of the patients was 49 years. A total of 40 patients (36%) had relapsed diseases after autologous stem cell transplantation and 36 patients (32%) had received radiotherapy. RIST regimens were fludarabine-based (n = 95), low-dose total body irradiation-based (n = 6) and others (n = 11). Cumulative incidences of grade II-IV acute graft-versus-host disease (GVHD) and chronic GVHD were, respectively, 49 and 59%. Cumulative incidences of progression and progression-free mortality were 18 and 25%, respectively. With a median follow-up of 23.9 months, 3-year overall survival rates were 59%. A multivariate analysis identified three significant factors for progression, which are history of radiation (relative risk (RR) 3.45, confidential interval (CI) 1.12-10.0, P = 0.03), central nervous system involvement (RR 6.25, CI 2.08-20.0, P = 0.001) and development of GVHD (RR 0.28, CI 0.090-0.86, P = 0.026). RIST may have decreased the rate of transplant-related mortality, and GVHD may have induced a graft-versus-lymphoma effect. However, whether or not these potential benefits can be directly translated into improved patient survival should be evaluated in further studies.

Original languageEnglish
Pages (from-to)205-213
Number of pages9
JournalBone Marrow Transplantation
Volume36
Issue number3
DOIs
Publication statusPublished - 2005 Aug

Fingerprint

Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Graft vs Host Disease
Lymphoma
Japan
Transplants
Mortality
Whole-Body Irradiation
Incidence
Radiotherapy
Multivariate Analysis
Survival Rate
Central Nervous System
Surveys and Questionnaires
Radiation
Survival

Keywords

  • Aggressive lymphoma
  • Graft-versus-host disease
  • Graft-versus-lymphoma effect
  • Indolent lymphoma
  • Nonmyeloablative hematopoietic stem cell transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma : A retrospective survey of 112 adult patients in Japan. / Kusumi, E.; Kami, M.; Kanda, Y.; Murashige, N.; Kishi, Y.; Suzuki, R.; Takeuchi, K.; Tanimoto, T. E.; Mori, Takehiko; Muta, K.; Tamaki, T.; Tanaka, Y.; Ogawa, H.; Yamane, T.; Taniguchi, S.; Takaue, Y.

In: Bone Marrow Transplantation, Vol. 36, No. 3, 08.2005, p. 205-213.

Research output: Contribution to journalArticle

Kusumi, E, Kami, M, Kanda, Y, Murashige, N, Kishi, Y, Suzuki, R, Takeuchi, K, Tanimoto, TE, Mori, T, Muta, K, Tamaki, T, Tanaka, Y, Ogawa, H, Yamane, T, Taniguchi, S & Takaue, Y 2005, 'Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: A retrospective survey of 112 adult patients in Japan', Bone Marrow Transplantation, vol. 36, no. 3, pp. 205-213. https://doi.org/10.1038/sj.bmt.1705027
Kusumi, E. ; Kami, M. ; Kanda, Y. ; Murashige, N. ; Kishi, Y. ; Suzuki, R. ; Takeuchi, K. ; Tanimoto, T. E. ; Mori, Takehiko ; Muta, K. ; Tamaki, T. ; Tanaka, Y. ; Ogawa, H. ; Yamane, T. ; Taniguchi, S. ; Takaue, Y. / Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma : A retrospective survey of 112 adult patients in Japan. In: Bone Marrow Transplantation. 2005 ; Vol. 36, No. 3. pp. 205-213.
@article{6e119f6357f045ab99271bbeb5e25bf0,
title = "Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: A retrospective survey of 112 adult patients in Japan",
abstract = "We conducted a nation-wide survey of 112 adult Japanese patients who underwent reduced-intensity stem cell transplantation (RIST) from 1999 to 2002. Underlying diseases included indolent (n = 45), aggressive (n = 58) and highly aggressive lymphomas (n = 9). Median age of the patients was 49 years. A total of 40 patients (36{\%}) had relapsed diseases after autologous stem cell transplantation and 36 patients (32{\%}) had received radiotherapy. RIST regimens were fludarabine-based (n = 95), low-dose total body irradiation-based (n = 6) and others (n = 11). Cumulative incidences of grade II-IV acute graft-versus-host disease (GVHD) and chronic GVHD were, respectively, 49 and 59{\%}. Cumulative incidences of progression and progression-free mortality were 18 and 25{\%}, respectively. With a median follow-up of 23.9 months, 3-year overall survival rates were 59{\%}. A multivariate analysis identified three significant factors for progression, which are history of radiation (relative risk (RR) 3.45, confidential interval (CI) 1.12-10.0, P = 0.03), central nervous system involvement (RR 6.25, CI 2.08-20.0, P = 0.001) and development of GVHD (RR 0.28, CI 0.090-0.86, P = 0.026). RIST may have decreased the rate of transplant-related mortality, and GVHD may have induced a graft-versus-lymphoma effect. However, whether or not these potential benefits can be directly translated into improved patient survival should be evaluated in further studies.",
keywords = "Aggressive lymphoma, Graft-versus-host disease, Graft-versus-lymphoma effect, Indolent lymphoma, Nonmyeloablative hematopoietic stem cell transplantation",
author = "E. Kusumi and M. Kami and Y. Kanda and N. Murashige and Y. Kishi and R. Suzuki and K. Takeuchi and Tanimoto, {T. E.} and Takehiko Mori and K. Muta and T. Tamaki and Y. Tanaka and H. Ogawa and T. Yamane and S. Taniguchi and Y. Takaue",
year = "2005",
month = "8",
doi = "10.1038/sj.bmt.1705027",
language = "English",
volume = "36",
pages = "205--213",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma

T2 - A retrospective survey of 112 adult patients in Japan

AU - Kusumi, E.

AU - Kami, M.

AU - Kanda, Y.

AU - Murashige, N.

AU - Kishi, Y.

AU - Suzuki, R.

AU - Takeuchi, K.

AU - Tanimoto, T. E.

AU - Mori, Takehiko

AU - Muta, K.

AU - Tamaki, T.

AU - Tanaka, Y.

AU - Ogawa, H.

AU - Yamane, T.

AU - Taniguchi, S.

AU - Takaue, Y.

PY - 2005/8

Y1 - 2005/8

N2 - We conducted a nation-wide survey of 112 adult Japanese patients who underwent reduced-intensity stem cell transplantation (RIST) from 1999 to 2002. Underlying diseases included indolent (n = 45), aggressive (n = 58) and highly aggressive lymphomas (n = 9). Median age of the patients was 49 years. A total of 40 patients (36%) had relapsed diseases after autologous stem cell transplantation and 36 patients (32%) had received radiotherapy. RIST regimens were fludarabine-based (n = 95), low-dose total body irradiation-based (n = 6) and others (n = 11). Cumulative incidences of grade II-IV acute graft-versus-host disease (GVHD) and chronic GVHD were, respectively, 49 and 59%. Cumulative incidences of progression and progression-free mortality were 18 and 25%, respectively. With a median follow-up of 23.9 months, 3-year overall survival rates were 59%. A multivariate analysis identified three significant factors for progression, which are history of radiation (relative risk (RR) 3.45, confidential interval (CI) 1.12-10.0, P = 0.03), central nervous system involvement (RR 6.25, CI 2.08-20.0, P = 0.001) and development of GVHD (RR 0.28, CI 0.090-0.86, P = 0.026). RIST may have decreased the rate of transplant-related mortality, and GVHD may have induced a graft-versus-lymphoma effect. However, whether or not these potential benefits can be directly translated into improved patient survival should be evaluated in further studies.

AB - We conducted a nation-wide survey of 112 adult Japanese patients who underwent reduced-intensity stem cell transplantation (RIST) from 1999 to 2002. Underlying diseases included indolent (n = 45), aggressive (n = 58) and highly aggressive lymphomas (n = 9). Median age of the patients was 49 years. A total of 40 patients (36%) had relapsed diseases after autologous stem cell transplantation and 36 patients (32%) had received radiotherapy. RIST regimens were fludarabine-based (n = 95), low-dose total body irradiation-based (n = 6) and others (n = 11). Cumulative incidences of grade II-IV acute graft-versus-host disease (GVHD) and chronic GVHD were, respectively, 49 and 59%. Cumulative incidences of progression and progression-free mortality were 18 and 25%, respectively. With a median follow-up of 23.9 months, 3-year overall survival rates were 59%. A multivariate analysis identified three significant factors for progression, which are history of radiation (relative risk (RR) 3.45, confidential interval (CI) 1.12-10.0, P = 0.03), central nervous system involvement (RR 6.25, CI 2.08-20.0, P = 0.001) and development of GVHD (RR 0.28, CI 0.090-0.86, P = 0.026). RIST may have decreased the rate of transplant-related mortality, and GVHD may have induced a graft-versus-lymphoma effect. However, whether or not these potential benefits can be directly translated into improved patient survival should be evaluated in further studies.

KW - Aggressive lymphoma

KW - Graft-versus-host disease

KW - Graft-versus-lymphoma effect

KW - Indolent lymphoma

KW - Nonmyeloablative hematopoietic stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=23744478874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744478874&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1705027

DO - 10.1038/sj.bmt.1705027

M3 - Article

VL - 36

SP - 205

EP - 213

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -